感染疾病诊断市场按技术、疾病类型（腹泻疾病、呼吸道感染疾病、血液感染疾病）、最终用户和地区划分

据估计，感染疾病诊断市场在 2025 年的价值为 17.508 亿美元，预计到 2032 年将达到 33.708 亿美元，从 2025 年到 2032 年的年复合成长率（CAGR）为 9.81%。

感染疾病是由细菌、病毒、真菌和寄生虫等微生物引起的，并且可以在不同物种之间传播。它们透过直接接触或间接途径（例如昆虫叮咬和食物、土壤、水和空气等污染物）在人与人之间传播。这些疾病的诊断包括识别病原体及其种类，并确定感染疾病是否正在扩散。诊断是疾病检测的第一步，而治疗则是根除疾病的关键。感染疾病是导致感染疾病和死亡率的主要原因之一。诊断在製定临床治疗策略中发挥重要作用。虽然感染疾病诊断对诊断病原体引起的疾病很有用，但像爱滋病、结核病、疟疾和流感等感染疾病非常普遍，可以使用针对每种疾病的诊断测试进行有效诊断。传统的感染疾病诊断耗时较长。这促使快速、准确、便携的就地检验产品在感染疾病诊断市场中涌现。就地检验在患者附近快速诊断感染疾病，并提供即时结果。目前，多位研究人员正在开发多重照护现场诊断技术。这些诊断测试中使用的技术可分为生化方法、分子技术、免疫诊断、传统培养方法和染色技术。生化方法包括酵素免疫分析法（ELISA）和凝集反应，而分子技术包括聚合酵素链锁反应（PCR）和次世代定序。这些测试能够以高通量准确诊断感染疾病。

市场动态

由于人们对早期疾病诊断的意识不断增强，感染疾病诊断市场日益普及预计将推动预测期内市场成长。例如，根据美国疾病管制与预防中心 (CDC) 1995 年发布的数据，美国医院每年因医院获得性感染 (HAI) 导致 170 万例感染和 9.9 万人死亡。在所有医疗相关感染疾病中，尿道感染占比高达 32%，其次是手术部位感染（22%）、肺炎（15%）和血流感染疾病（14%）。

本次调查的主要特点

• 本报告对全球感染疾病诊断市场进行了详细分析，以 2024 年为基准年，给出了 2025 年至 2032 年的市场规模和复合年增长率 (%)。
• 它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数介绍了全球感染疾病诊断市场主要企业的概况：公司概况、财务表现、产品系列、地理扩张、分销策略、主要发展、策略和未来计划。
• 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球感染疾病诊断市场报告针对该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 透过市场分析中使用的各种策略矩阵，相关人员将能够轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监管与趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • 市场吸引力分析
  • 市场机会
  • 产品发布
  • 合併、收购和合作
• 监管准则和合规性
• 重大进展
• PEST分析

4. 2020-2032年全球感染疾病诊断市场（依技术划分）

• ELISA
• 聚合酵素链锁反应（PCR）
• 免疫检测
• 细胞培养
• 其他的

5. 2020-2032年全球感染疾病诊断市场（依疾病分类）

• 中枢神经系统感染疾病
• 脑膜炎
• 脑脓肿
• 腹泻疾病
• 痢
• 霍乱
• 伤寒
• 呼吸道感染疾病
• 结核
• 流感
• 支气管炎
• 血液感染疾病
• 疟疾
• 登革热
• 传染性单核球增多症
• 其他的
• 性行为感染传染病（STD）
• 披衣菌感染
• 爱滋病
• 梅毒
• 其他的

6. 2020-2032年全球感染疾病诊断市场（依最终用户划分）

• 医院
• 门诊手术中心
• 皮肤科诊所
• 其他（研究机构、专业中心等）

7. 2020-2032年全球感染疾病诊断市场（依地区划分）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • GCC
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 中非
  • 南非

第八章 竞争情势

• Becton Dickinson & Company
• Cepheid, Inc.
• Abbott Laboratries
• BioMerieux
• Hologic, Inc.
• Danaher Corportion
• Thermo Fisher Scientific, Inc.
• Roche Diagnostics
• DiaSorin SpA
• Quidel Corporation
• Bio-Rad Laboratories, Inc

第九章各节

• 调查方法
• 关于本公司

Infectious Disease Diagnostics Market is estimated to be valued at USD 1,750.8 Mn in 2025 and is expected to reach USD 3,370.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.81% from 2025 to 2032.

Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Market Dynamics

Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].

Key features of the study

• This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

• Technology Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • ELISA
  • Polymerase Chain Reaction
  • Immunoassays
  • Cell Cultures
  • Others
• Disease Indication Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • Central nervous system (CNS) Infection
  • Meningitis
  • Brain Abscess
  • Diarrheal Disease
  • Shigellosis
  • Cholera
  • Enteric/Typhoid Fever
  • Respiratory Infections
  • Tuberculosis
  • Influenza
  • Bronchitis
  • Blood Infections
  • Malaria
  • Dengue
  • Infectious Mononucleosis
  • Others
  • STDs
  • Chlamydia
  • AIDS
  • Syphilis
  • Others
• End User Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • Hospitals
  • Diagnostics centers
  • Dermatology Clinics
  • Others (Research Institutes, Specialty Centres, etc.)
• Regional Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players Insights
  • Becton Dickinson & Company
  • Cepheid, Inc
  • Abbott Laboratories
  • BioMerieux SA
  • Hologic, Inc
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc
  • Roche Diagnostics
  • DiaSorin S.p.A
  • Quidel Corporation
  • Bio-Rad Laboratories

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End Users
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis

4. Global Infectious Disease Diagnostics Market, By Technology, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• ELISA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • Segment Trends
• Polymerase Chain Reaction (PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Immunoassays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Cell Cultures
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends

5. Global Infectious Disease Diagnostics Market , By Disease Indication 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Central Nervous System Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Meningitis
• Brain Abscess
• Diarrheal Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Shigellosis
• Cholera
• Enteric/Typhoid Fever
• Respiratory Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Tuberculosis
• Influenza
• Bronchitis
• Blood Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Malaria
• Dengue
• Infectious Mononucleosis
• Others
• Sexually transmitted diseases (STDs),
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Chlamydia
• AIDS
• Syphilis
• Others

6. Global Infectious Disease Diagnostics Market , By End Users 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Dermatology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Research Institutes, Specialty Centers, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Infectious Disease Diagnostics Market , By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Becton Dickinson & Company
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Cepheid, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Abbott Laboratries
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• BioMerieux
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Danaher Corportion
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Quidel Corporation
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies

9. Section

• Research Methodology
• About Us